{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Complicated+Intra-abdominal+Infections", "query": { "condition": "Complicated Intra-abdominal Infections" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 22, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Complicated+Intra-abdominal+Infections&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T07:47:51.260Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02784704", "title": "Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Intra-abdominal Infections", "Complicated Appendicitis" ], "interventions": [ { "name": "Eravacycline", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tetraphase Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2016-10-13", "completion_date": "2017-05-19", "has_results": true, "last_update_posted_date": "2022-01-06", "last_synced_at": "2026-05-22T07:47:51.260Z", "location_count": 6, "location_summary": "Los Angeles, California • Indianapolis, Indiana • Las Vegas, Nevada + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Somers Point", "state": "New Jersey" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02784704" }, { "nct_id": "NCT00752219", "title": "Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Complicated Intra-abdominal Infections" ], "interventions": [ { "name": "ceftazidime/NXL104 + metronidazole", "type": "DRUG" }, { "name": "meropenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 204, "start_date": "2009-03-31", "completion_date": "2009-12-31", "has_results": true, "last_update_posted_date": "2018-07-03", "last_synced_at": "2026-05-22T07:47:51.260Z", "location_count": 9, "location_summary": "Los Angeles, California • Palm Springs, California • Detroit, Michigan + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palm Springs", "state": "California" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Butte", "state": "Montana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00752219" }, { "nct_id": "NCT01844856", "title": "Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Intra-abdominal Infections" ], "interventions": [ { "name": "Eravacycline", "type": "DRUG" }, { "name": "Ertapenem", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tetraphase Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 541, "start_date": "2013-08", "completion_date": "2014-08", "has_results": true, "last_update_posted_date": "2022-01-11", "last_synced_at": "2026-05-22T07:47:51.260Z", "location_count": 19, "location_summary": "Florence, Alabama • Mobile, Alabama • Glendale, California + 16 more", "locations": [ { "city": "Florence", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01844856" }, { "nct_id": "NCT03358576", "title": "Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Intra Abdominal Infections" ], "interventions": [ { "name": "Ertapenem", "type": "DRUG" }, { "name": "Sulopenem-Etzadroxil/Probenecid", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Metronidazole", "type": "DRUG" }, { "name": "Amoxicillin-Clavulanate", "type": "DRUG" }, { "name": "Sulopenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Iterum Therapeutics, International Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 674, "start_date": "2018-09-18", "completion_date": "2019-10-02", "has_results": true, "last_update_posted_date": "2020-12-01", "last_synced_at": "2026-05-22T07:47:51.260Z", "location_count": 12, "location_summary": "Chula Vista, California • Torrance, California • Idaho Falls, Idaho + 8 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Idaho Falls", "state": "Idaho" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Royal Oak", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03358576" }, { "nct_id": "NCT01644643", "title": "Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Urinary Tract Infection", "Complicated Intra-abdominal Infection" ], "interventions": [ { "name": "Ceftazidime - Avibactam ( CAZ-AVI)", "type": "DRUG" }, { "name": "Best Available Therapy", "type": "DRUG" }, { "name": "Metronidazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 345, "start_date": "2013-01", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2017-09-29", "last_synced_at": "2026-05-22T07:47:51.260Z", "location_count": 2, "location_summary": "Shreveport, Louisiana • Lima, Ohio", "locations": [ { "city": "Shreveport", "state": "Louisiana" }, { "city": "Lima", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01644643" }, { "nct_id": "NCT03217136", "title": "MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Complicated Intra-Abdominal Infection" ], "interventions": [ { "name": "Ceftolozane/Tazobactam", "type": "DRUG" }, { "name": "Metronidazole", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Placebo for Metronidazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Days", "maximum_age": "17 Years", "sex": "ALL", "summary": "7 Days to 17 Years" }, "enrollment_count": 94, "start_date": "2018-04-03", "completion_date": "2020-03-16", "has_results": true, "last_update_posted_date": "2023-05-06", "last_synced_at": "2026-05-22T07:47:51.260Z", "location_count": 9, "location_summary": "Los Angeles, California • Orange, California • San Diego, California + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03217136" }, { "nct_id": "NCT00621192", "title": "Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Necrotizing Enterocolitis", "Intra-abdominal Infection" ], "interventions": [ { "name": "meropenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Emmes Company, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "90 Days", "sex": "ALL", "summary": "Up to 90 Days" }, "enrollment_count": 200, "start_date": "2008-06", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2023-04-25", "last_synced_at": "2026-05-22T07:47:51.260Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Oakland, California • Orange, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Oakland", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00621192" }, { "nct_id": "NCT06086626", "title": "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gram-Negative Bacterial Infections" ], "interventions": [ { "name": "Cefiderocol", "type": "DRUG" }, { "name": "Standard of Care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shionogi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "3 Months", "sex": "ALL", "summary": "Up to 3 Months" }, "enrollment_count": 30, "start_date": "2024-03-14", "completion_date": "2025-03-31", "has_results": false, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-05-22T07:47:51.260Z", "location_count": 2, "location_summary": "Little Rock, Arkansas • Durham, North Carolina", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06086626" }, { "nct_id": "NCT00195351", "title": "Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Appendicitis", "Cholecystitis", "Cross Infection", "Diverticulitis", "Peritonitis" ], "interventions": [ { "name": "tigecycline", "type": "DRUG" }, { "name": "ceftriaxone sodium + metronidazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 467, "start_date": "2005-09", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2013-02-25", "last_synced_at": "2026-05-22T07:47:51.260Z", "location_count": 46, "location_summary": "Mobile, Alabama • Laguna Hills, California • Los Angeles, California + 38 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Laguna Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palm Springs", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00195351" }, { "nct_id": "NCT01147640", "title": "Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Complicated Intra-abdominal Infection" ], "interventions": [ { "name": "CXA-101/ tazobactam and metronidazole", "type": "DRUG" }, { "name": "meropenem plus saline placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 122, "start_date": "2010-06-25", "completion_date": "2011-03-25", "has_results": true, "last_update_posted_date": "2018-10-25", "last_synced_at": "2026-05-22T07:47:51.260Z", "location_count": 11, "location_summary": "Orange, California • Torrance, California • Aurora, Colorado + 8 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Newark", "state": "Delaware" }, { "city": "Pensacola", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01147640" } ] }